ICVX Share Price Performance
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
Icosavax, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ICVX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Icosavax, Inc. Key Details
About ICVX
- Founded
- 2017
- Employees
- 60
- CEO
- WebsiteView website
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington.
